Retail was Cresco Labs’s largest segment in fiscal 2025, bringing in $433.08M of $655.85M (66%).
| Segment | FY 2024 | FY 2025 |
|---|---|---|
| Retail | $471.75M | $433.08M |
| Wholesale | $252.59M | $222.77M |
| Total | $724.34M | $655.85M |
Cresco Labs brought in $655.85M from its two segments in fiscal 2025, the year ended December 31, 2025. That was down 9.5% from $724.34M in fiscal 2024. Retail was the largest at $433.08M (66.0%), ahead of Wholesale at $222.77M (34.0%).
Compared with fiscal 2024, Retail fell 8.2% to $433.08M and Wholesale fell 11.8% to $222.77M.
Other Entities Including Cresco Labs Llc was Cresco Labs’s largest revenue line in fiscal 2021, bringing in $663.60M of $813.76M (82%).
| Consolidated Entities | FY 2019 | FY 2020 | FY 2021 |
|---|---|---|---|
| Other Entities Including Cresco Labs Llc | $99.29M | $386.26M | $663.60M |
| Medmar Inc. (Rockford) | — | — | $84.93M |
| Cresco Labs Ohio, Llc | — | $14.65M | $22.66M |
| Medmar Inc Rockford | $5.31M | $38.42M | — |
| Tsc Cresco, Llc | — | $16.87M | $21.55M |
| Slo Cultivation Inc | $21.15M | $19.77M | $21.01M |
| Medmar Inc Lakeview | $4.09M | — | — |
| Total | $129.84M | $475.97M | $813.76M |
Cresco Labs brought in $813.76M from its five revenue lines in fiscal 2021, the year ended December 31, 2021. Cresco Labs regrouped these revenue lines after fiscal 2020, so the total does not compare directly with that year's $475.97M. Other Entities Including Cresco Labs Llc was the largest at $663.60M (81.5%), ahead of Medmar Inc. (Rockford) at $84.93M (10.4%) and Cresco Labs Ohio, Llc at $22.66M (2.8%). The other two revenue lines brought in $42.56M combined.
Compared with fiscal 2020, Other Entities Including Cresco Labs Llc grew fastest, up 71.8% to $663.60M. Every revenue line above 2% of revenue grew.
Cresco Labs began breaking out Medmar Inc. (Rockford) in fiscal 2021, Cresco Labs Ohio, Llc in fiscal 2020 and Tsc Cresco, Llc in fiscal 2020. Cresco Labs stopped reporting Medmar Inc Rockford ($38.42M in fiscal 2020) and Medmar Inc Lakeview ($4.09M in fiscal 2019) as separate revenue lines.
Dispensary was Cresco Labs’s largest product and service line in fiscal 2023, bringing in $464.52M of $770.89M (60%).
| Product and Service | FY 2023 |
|---|---|
| Dispensary | $464.52M |
| Wholesale | $306.36M |
| Total | $770.89M |
Cresco Labs brought in $770.89M from its two product and service lines in fiscal 2023, the year ended December 31, 2023. Dispensary was the largest at $464.52M (60.3%), ahead of Wholesale at $306.36M (39.7%).
Cresco Labs (CRLBF) reports its revenue by segment, by consolidated entities and by product and service. In fiscal 2025, Retail was its largest segment, bringing in $433.08M (66.0% of the total), followed by Wholesale at $222.77M (34.0%).
Retail was Cresco Labs' largest segment in fiscal 2025, bringing in $433.08M, or 66.0% of the $655.85M total across its two segments.
Other Entities Including Cresco Labs Llc was Cresco Labs' largest revenue line in fiscal 2021, bringing in $663.60M, or 81.5% of the $813.76M total across its five revenue lines.
Dispensary was Cresco Labs' largest product and service line in fiscal 2023, bringing in $464.52M, or 60.3% of the $770.89M total across its two product and service lines.
Every figure comes from Cresco Labs' annual financial filings, as reported. Each line keeps the name Cresco Labs gives it, and years follow its fiscal calendar.
Cresco Labs' revenue by segment goes back to fiscal 2024, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.